Compugen (CGEN) director Eran Perry details shares, RSUs and options
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Compugen Ltd. director Eran Perry has filed an initial Form 3 reporting his equity holdings in the company. He directly owns 10,000 Ordinary Shares and 9,216 restricted stock units, which vest in scheduled quarterly installments starting on April 1, 2026 and October 1, 2026, subject to continued service. He also holds multiple share options over Ordinary Shares with exercise prices ranging from $1.15 to $14.40 per share and expiration dates between July 1, 2029 and August 5, 2035, with portions already vested and the remainder vesting in equal quarterly installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Perry Eran
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option (right to buy) — 35,000 shares (Direct);
Ordinary Shares — 10,000 shares (Direct)
Footnotes (1)
- Includes 9,216 restricted stock units ("RSUs"). 1,716 RSUs vest in 11 equal quarterly installments commencing on April 1, 2026; and 7,500 RSUs vest 25% on October 1, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Fully vested. This option vested 25% on April 1, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vested 25% on October 1, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vested 25% on October 1, 2025 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vests 25% on October 1, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
FAQ
What does Compugen (CGEN) director Eran Perry report in this Form 3?
Eran Perry reports his initial equity holdings in Compugen, including 10,000 Ordinary Shares, 9,216 restricted stock units, and several option grants over Ordinary Shares. The filing outlines vesting schedules and option expiration dates, establishing his baseline ownership as a company director.
What restricted stock units (RSUs) are disclosed for Eran Perry at Compugen (CGEN)?
The filing states Perry holds 9,216 restricted stock units. Of these, 1,716 RSUs vest in 11 equal quarterly installments from April 1, 2026, and 7,500 RSUs vest 25% on October 1, 2026, with the balance vesting in 12 quarterly installments, subject to continued service.
Does this Compugen (CGEN) Form 3 show any recent insider buying or selling?
The Form 3 lists holdings rather than new transactions, so it does not show recent buying or selling activity. It simply records Perry’s existing Ordinary Shares, RSUs, and option positions as his initial statement of beneficial ownership as a director.
How do Eran Perry’s Compugen (CGEN) RSUs vest over time?
1,716 RSUs vest in 11 equal quarterly installments starting April 1, 2026. Another 7,500 RSUs vest 25% on October 1, 2026, with the remaining 75% vesting in 12 equal quarterly installments, all subject to his continued service with Compugen.